arrow
M

Matthieu Foll

Centre International de Recherche sur le Cancer
H指数:43
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids

肺神经内分泌肿瘤和类癌的深层分子谱分析

2026-08-270
OA
Digital Immunophenotyping of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Subtypes With Specific Tumor-Immune Microenvironment Features

肺不典型类癌和大细胞神经内分泌癌的数字免疫分型识别出具有特定肿瘤-免疫微环境特征的三个亚型

2025-10-240
OA
Understanding the biological processes of kidney carcinogenesis: an integrative multi-omics approach

了解肾脏癌变的生物学过程: 一种整合的多组学方法

2024-11-260
PRE
Assessment of the current and emerging criteria for the histopathological classification of lung neuroendocrine tumours in the lungNENomics project
2024-06-011
OAAI
Clinical management of typical and atypical carcinoids/neuroendocrine tumors in ENETS centres of excellence (CoE): Survey from the ENETS lung NET task force
2024-05-163
PRE
Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery
2023-12-043
OAAI
Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity
2023-03-1627
OAAI
Genetic Analysis of Lung Cancer and the Germline Impact on Somatic Mutation Burden
2022-05-029
OAAI
Circulating tumour-derived KRAS mutations in pancreatic cancer cases are predominantly carried by very short fragments of cell-free DNA
2020-05-0113
OAAI
Needlestack: an ultra-sensitive variant caller for multi-sample next generation sequencing data
2020-04-207
OAAI
Urinary TERT promoter mutations are detectable up to 10 years prior to clinical diagnosis of bladder cancer: Evidence from the Golestan Cohort Study
2020-03-0156
OAAI